Aqr Capital Management LLC Relmada Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.24 - $4.76 $14,891 - $31,644	6,648 Added 21.91%	36,991 $83,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $65,844 - $1.09 Million	30,343 New	30,343 $105,000
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $228,761 - $304,708	-7,656 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.42 - $43.78 $263,519 - $335,179	7,656 New	7,656 $288,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.